Frequently Asked Questions
The market is segmented based on Global Randomization and Trial Supply Management (RTSM) Market, By Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions), Clinical Trial Phase (Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV Clinical Trials), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, Academic Research Institutes) – Industry Trends and Forecast to 2029
.
The Global Randomization And Trial Supply Management Rtsm Market size was valued at USD 0.17 USD Billion in 2021.
The Global Randomization And Trial Supply Management Rtsm Market is projected to grow at a CAGR of 15% during the forecast period of 2022 to 2029.
The major players operating in the market include MEDICAL Information Technology , SAP, CPSI, Meta, Elinext, EPIC Systems Corporation, INFOR, Cognizant, Oracle, Jag products LLC, Allscripts Healthcare LLC, Optum , Cerner Corporation, Change Healthcare, Koninklijke Philips N.V., athenahealth, eClinicalWorks.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
